Detalhe da pesquisa
1.
Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
Antimicrob Agents Chemother
; 60(8): 4853-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270285
2.
Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum.
Antimicrob Agents Chemother
; 59(4): 1977-82, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25605352
3.
ELQ-300 prodrugs for enhanced delivery and single-dose cure of malaria.
Antimicrob Agents Chemother
; 59(9): 5555-60, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26124159
4.
Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy.
Am J Trop Med Hyg
; 92(6): 1195-201, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25918204
5.
Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers.
J Med Chem
; 57(9): 3818-34, 2014 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24720377